Cardiometabolic diseases and the number-one cause of death in the world. These include cardiovascular disease (CVD), diabetes mellitus, and insulin resistance. These diseases may begin with insulin resistance and progress to metabolic syndrome. Cardiometabolic disease describes a spectrum of conditions beginning with insulin resistance, progressing to the metabolic syndrome, pre-diabetes, and finally to more severe conditions including cardiovascular disease (CVD) and type 2 diabetes (T2DM) (Guo et al., 2014). These conditions are grouped under the umbrella term “cardiometabolic disease” as they are related or share risk factors, such as overweight and obesity, dyslipidemia, and high blood pressure.
To reduce the risk of developing cardiometabolic disease, research and public health interventions have traditionally focused on increasing physical activity, improving diet quality, and reducing tobacco use and alcohol intake.